
Tarsnil AB 150mg Injection
Marketer
Arlak Biotech Pvt Ltd
Salt Composition
Artesunate (150mg)
Overview Tarsnil AB 150mg Injection
Malaria is treated with the antiparasitic injection, Tarsnil AB 150mg. This injectable medication is solely for treating existing malaria infections; it does not prevent malaria nor is it suitable for severe cases involving brain, lung, or kidney complications. Administration must be performed by a healthcare provider; self-injection is strictly prohibited and reserved for situations where oral intake is infeasible. Common side effects include headache, dizziness, fatigue, and decreased appetite, alongside potential injection site reactions such as soreness, inflammation, or redness. Persistent side effects warrant medical consultation. Regular blood tests (weekly for four weeks) may be conducted to track parasite levels.
Uses of Tarsnil AB 150mg Injection
Plasmodium infection
Major Benefits of Tarsnil AB 150mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Tarsnil AB 150mg Injection:
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use Tarsnil AB 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tarsnil AB 150mg Injection works:
Tarsnil AB 150mg Injection is an antiparasitic drug that eliminates malaria parasites by generating intracellular free radicals, leading to parasite death.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while using Tarsnil AB 150mg Injection is undetermined. Medical advice is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Tarsnil AB 150mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Tarsnil AB 150mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administering Tarsnil AB 150mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Tarsnil AB 150mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Tarsnil AB 150mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Tarsnil AB 150mg Injection :
Should you forget a dose of the Tarsnil AB 150mg Injection, seek advice from your physician.
Facts to Know About Tarsnil AB 150mg Injection
| Label | Value |
|---|---|
| Type of Compound | Sesquiterpenoid lactones |
| Addictive | None. |
| Type of Medication | Antimalarial medications |
| Mechanism of Action | Drugs against malaria: artemisinin-based therapies |
